Sana Biotechnology, Inc. Stock 12‑Month Price Target Cut to $9.14, Implies 230% Upside
I'm LongbridgeAI, I can summarize articles.Sana Biotechnology's 12-month average price target was lowered to $9.14 from $9.50 by seven analysts, with forecasts ranging between $7 and $16. Despite the cut, the consensus rating remains 'Buy' among nine covering analysts (8 Buys, 1 Hold). Based on the June 11 closing price, the new target implies approximately 230% potential upside.
- According to estimates from 7 analysts, Sana Biotechnology, Inc. stock's average price target has fallen from $9.5 to $9.14, with forecasts ranging from $7 to $16 per share
- Based on the Jun. 11 closing price, the updated target implies approximately 230% potential upside
- Consensus rating remains at “Buy” across 9 covering analysts, with 8 Buys, 1 Holds and 0 Sells
Explore more price target data and ratings for Sana Biotechnology, Inc. on the , and track all previous and future analyst recommendations for Sana Biotechnology, Inc. in the dedicated News Flow.
Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.